CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −19,602 | $40.24 | $789K | 250,445 |
| 2022-10-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −4,901 | $40.24 | $197K | 191,337 |
| 2022-10-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −19,602 | 1,494,513 | ||
| 2022-10-06 | Schlanger David J Executive Chairman | Exercise or conversion | +56,852 | $0.91 | $52K | 139,400 |
| 2022-10-06 | Schlanger David J Executive Chairman | Sale | −56,852 | $40.26 | $2.3M | 82,548 |
| 2022-10-06 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −56,852 | 1,422,878 | ||
| 2022-10-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Gift | −74,471 | 250,445 | ||
| 2022-10-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Gift | +74,471 | 196,598 | ||
| 2022-10-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +1,440 | $3.95 | $6K | 251,885 |
| 2022-10-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,440 | $40.18 | $58K | 250,445 |
| 2022-10-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −360 | $40.18 | $14K | 196,238 |
| 2022-10-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Option (Right to Buy) | −1,440 | 1,514,115 | ||
| 2022-10-05 | Schlanger David J Executive Chairman | Exercise or conversion | +3,950 | $0.91 | $4K | 86,498 |
| 2022-10-05 | Schlanger David J Executive Chairman | Sale | −3,950 | $40.18 | $159K | 82,548 |
| 2022-10-05 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −3,950 | 1,479,730 | ||
| 2022-09-29 | Payson Norman Director | Sale | −6,092 | $38.09 | $232K | 352,376 |
| 2022-09-29 | Payson Norman Director | Sale | −526 | $38.64 | $20K | 351,850 |
| 2022-09-28 | Payson Norman Director | Sale | −1,900 | $38.54 | $73K | 363,186 |
| 2022-09-28 | Payson Norman Director | Sale | −4,718 | $39.07 | $184K | 358,468 |
| 2022-09-15 | Payson Norman Director | Sale | −5,718 | $42.41 | $243K | 365,986 |
Page 42 of 77 · 1,524 trades